T1	Treatment 0 29	Active specific immunotherapy
T2	Treatment 226 255	active specific immunotherapy
T3	Treatment 501 544	postoperative ASI or no adjuvant treatment.
T4	Treatment 672 696	autologous tumour cells.
T5	Treatment 1065 1068	ASI
